Eco Animal Health Regulatory Approval

 
TIDMEAH 
 
 

ECO Animal Health Group plc (AIM: EAH)

ECO RECEIVES USA MARKETING AUTHORISATION FOR AIVLOSIN® FOR SWINE RESPIRATORY DISEASE

ECO Animal Health Group plc is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a marketing authorisation for Aivlosin® in the United States from the Center for Veterinary Medicine (CVM) of the Food and Drug Administration (FDA).

Aivlosin®, ECO's patented antimicrobial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry.

This authorisation is for the use of Aivlosin® 625 mg/g water soluble granules in for the control of swine respiratory disease (SRD) associated with Bordetella bronchiseptica, Haemophilus parasuis, Pasteurella multocida, and Streptococcus suis, four important bacterial respiratory pathogens of swine.

This new treatment meets all the guidelines for the responsible use of antimicrobials. Importantly, with global concerns about the use of antibiotics in food production animals, this treatment is under the control of veterinarians, is available under prescription only and has a low, highly effective therapeutic dose rate, short treatment duration and a zero day drug withholding period.

The product will be marketed through Pharmgate Animal Health LLC our well-established sales and marketing joint venture formed in 2010 with Pharmgate LLC, the majority-owned U.S. subsidiary of Jinhe Biotechnology Co. Ltd. in China.

Peter Lawrence, Chairman of ECO, commented "We are extremely pleased to receive this second marketing authorisation for the Aivlosin® water soluble granules formulation in the United States. The swine respiratory disease segment is a key one and this latest approval demonstrates ECO's continued progress to becoming a major force in the international market for veterinary pharmaceutical products."

This announcement contains inside information.

Contacts:

ECO Animal Health Group plc

 
Peter Lawrence                                  020 8336 6190 
Marc Loomes                                     020 8447 6906 
Spiro Financial 
Anthony Spiro                                   020 8336 6196 
Peel Hunt LLP (Nominated Adviser) 
Dan Webster, Adrian Trimmings, George Sellar    020 7418 8900 
N+1 Singer (Joint Broker)                       020 7496 3000 
Mark Taylor, Brough Ransom 
 
 

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders

View source version on businesswire.com: http://www.businesswire.com/news/home/20170723005030/en/

 
This information is provided by Business Wire 
 
 

(END) Dow Jones Newswires

July 24, 2017 02:00 ET (06:00 GMT)